{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:26:18Z","timestamp":1793694378845,"version":"4.5.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15852-3","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:53:16Z","timestamp":1773978796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CALLY index provides improved prognostic stratification compared with other inflammation-based scores in glioblastoma treated with the stupp protocol"],"prefix":"10.1186","volume":"26","author":[{"given":"Beril","family":"Balci Topuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Ozturk Iyilikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"15852_CR1","doi-asserted-by":"crossref","unstructured":"Jarmuzek P, Kozlowska K, Defort P et al. Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis. Vol. 15, Cancers. Multidisciplinary Digital Publishing Institute (MDPI); 2023.","DOI":"10.3390\/cancers15133339"},{"issue":"5","key":"15852_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459\u201366. https:\/\/doi.org\/10.1016\/S1470-2045(09)70025-7.","journal-title":"Lancet Oncol"},{"key":"15852_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137.","journal-title":"Nature"},{"key":"15852_CR4","doi-asserted-by":"crossref","unstructured":"Grivennikov SI, Greten FR, Karin M, Immunity. Inflammation, and Cancer. Vol. 140, Cell. 2010. pp. 883\u201399.","DOI":"10.1016\/j.cell.2010.01.025"},{"key":"15852_CR5","doi-asserted-by":"crossref","unstructured":"Ji F, Fu S, Guo Z et al. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection. Vol. 7, Oncotarget. Available from: https:\/\/www.impactjournals.com\/oncotarget\/","DOI":"10.18632\/oncotarget.10848"},{"issue":"6","key":"15852_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/jso.27210","volume":"127","author":"L Sun","year":"2023","unstructured":"Sun L, Liu J, Wang D. Prognostic value of the preoperative prognostic nutritional index and systemic immuno-inflammatory index in Chinese breast cancer patients: A clinical retrospective cohort study. J Surg Oncol. 2023;127(6):921\u20138.","journal-title":"J Surg Oncol"},{"issue":"12","key":"15852_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-014-0305-0","volume":"31","author":"HQ Ying","year":"2014","unstructured":"Ying HQ, Deng QW, He BS, et al. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Med Oncol. 2014;31(12):1\u20138.","journal-title":"Med Oncol"},{"issue":"2","key":"15852_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.21037\/atm-22-5612","volume":"11","author":"B Shao","year":"2023","unstructured":"Shao B, Li H, Liu X, et al. The prognostic value of neutrophil-to-lymphocyte ratio in de novo stage IV breast cancer: a retrospective cohort study. Ann Transl Med. 2023;11(2):45\u201345.","journal-title":"Ann Transl Med"},{"issue":"5","key":"15852_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.56434\/j.arch.esp.urol.20227505.68","volume":"75","author":"H Chen","year":"2022","unstructured":"Chen H, Wu X, Wen Z, et al. The Clinicopathological and Prognostic Value of NLR, PLR and MLR in Non-Muscular Invasive Bladder Cancer. Arch Esp Urol. 2022;75(5):467\u201371.","journal-title":"Arch Esp Urol"},{"key":"15852_CR10","doi-asserted-by":"crossref","unstructured":"Bailey-Whyte M, Minas TZ, Dorsey TH et al. Systemic Inflammation Indices and Association with Prostate Cancer Survival in a Diverse Patient Cohort. Cancers (Basel). 2023;15(6).","DOI":"10.3390\/cancers15061869"},{"key":"15852_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/cancers17132189","volume":"17","author":"FP Bizzarri","year":"2025","unstructured":"Bizzarri FP, Campetella M, Russo P, et al. Prognostic Value of PLR, SIRI, PIV, SII, and NLR in Non-Muscle Invasive Bladder Cancer: Can Inflammatory Factors Influence Pathogenesis and Outcomes? Cancers (Basel). 2025;17:13.","journal-title":"Cancers (Basel)"},{"key":"15852_CR12","doi-asserted-by":"publisher","first-page":"1676824","DOI":"10.3389\/fonc.2025.1676824","volume":"15","author":"Z Li","year":"2025","unstructured":"Li Z, An W, Wang B, et al. Prognostic significance of peripheral blood inflammatory biomarkers (SII, PLR, NLR, LMR, SIRI, PIV, PNI) in lip cancer: NLR as an independent biomarker for survival outcomes. Front Oncol. 2025;15:1676824. https:\/\/doi.org\/10.3389\/fonc.2025.1676824.","journal-title":"Front Oncol"},{"issue":"3","key":"15852_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3171\/2017.3.JNS161648","volume":"129","author":"SH Zheng","year":"2018","unstructured":"Zheng SH, Huang JL, Chen M, et al. Diagnostic value of preoperative inflammatory markers in patients with glioma: A multicenter cohort study. J Neurosurg. 2018;129(3):583\u201392.","journal-title":"J Neurosurg"},{"key":"15852_CR14","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Heredia A, Guerra-N\u00fa\u00f1ez L, Iriarte-Gahete M et al. Tumour immune infiltration is independent of peripheral circulation of white blood cells in glioblastoma. Sci Rep. 2025;15(1).","DOI":"10.1038\/s41598-025-16260-6"},{"issue":"4","key":"15852_CR15","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s11845-024-03666-w","volume":"193","author":"UO Mutlucan","year":"2024","unstructured":"Mutlucan UO, Bedel C, Selvi F, et al. The effect of indicators of CALLY index on survival in glioblastoma. Ir J Med Sci. 2024;193(4):2029\u201333.","journal-title":"Ir J Med Sci"},{"key":"15852_CR16","doi-asserted-by":"crossref","unstructured":"McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Vol. 12, Current Opinion in Clinical Nutrition and Metabolic Care. 2009. pp. 223\u20136.","DOI":"10.1097\/MCO.0b013e32832a7902"},{"key":"15852_CR17","unstructured":"Lam P, Leung M, Tse C. Identifying prognostic factors for survival in advanced cancer patients: a prospective study. 2007. Available from: www.hkmj.org."},{"key":"15852_CR18","doi-asserted-by":"crossref","unstructured":"Wu B, Liu J, Shao C, et al. Integrating inflammation, nutrition, and immunity: the CALLY index as a prognostic tool in digestive system cancers - a systematic review and meta-analysis. Volume 25. BMC Cancer. BioMed Central Ltd; 2025.","DOI":"10.1186\/s12885-025-14074-3"},{"key":"15852_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers13195018","volume":"13","author":"L M\u00fcller","year":"2021","unstructured":"M\u00fcller L, Hahn F, M\u00e4hringer-kunz A, et al. Immunonutritive scoring for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: Evaluation of the cally index. Cancers (Basel). 2021;13:19.","journal-title":"Cancers (Basel)"},{"key":"15852_CR20","doi-asserted-by":"crossref","unstructured":"Kawahara S, Aoyama T, Murakawa M et al. Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancer. Langenbecks Arch Surg. 2024;409(1).","DOI":"10.1007\/s00423-024-03512-8"},{"issue":"6","key":"15852_CR21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.21873\/cdp.10391","volume":"4","author":"H Hirata","year":"2024","unstructured":"Hirata H, Fujii N, Oka S, et al. C-reactive Protein-albumin-lymphocyte Index as a Novel Biomarker for Progression in Patients Undergoing Surgery for Renal Cancer. Cancer Diagnosis Prognosis. 2024;4(6):748\u201353.","journal-title":"Cancer Diagnosis Prognosis"},{"key":"15852_CR22","doi-asserted-by":"crossref","unstructured":"Yang M, Lin SQ, Liu XY et al. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study. Front Immunol. 2023;14.","DOI":"10.3389\/fimmu.2023.1131496"},{"key":"15852_CR23","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.2147\/CMAR.S359968","volume":"14","author":"W Wang","year":"2022","unstructured":"Wang W, Gu J, Liu Y, et al. Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer. Cancer Manag Res. 2022;14:2803\u201312.","journal-title":"Cancer Manag Res"},{"key":"15852_CR24","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2147\/IJGM.S447201","volume":"17","author":"J Zhuang","year":"2024","unstructured":"Zhuang J, Wang S, Wang Y, et al. Prognostic Value of CRP\u2013Albumin\u2013Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer. Int J Gen Med. 2024;17:997\u20131005.","journal-title":"Int J Gen Med"},{"key":"15852_CR25","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.2147\/JIR.S460109","volume":"17","author":"T Jiang","year":"2024","unstructured":"Jiang T, Sun H, Xu T, et al. Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective. J Inflamm Res. 2024;17:3353\u201369.","journal-title":"J Inflamm Res"},{"key":"15852_CR26","doi-asserted-by":"crossref","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis. Journal of the National Cancer Institute. Volume 106. Oxford University Press; 2014.","DOI":"10.1093\/jnci\/dju124"},{"key":"15852_CR27","doi-asserted-by":"crossref","unstructured":"Stepanenko AA, Sosnovtseva AO, Valikhov MP, et al. Systemic and local immunosuppression in glioblastoma and its prognostic significance. Frontiers in Immunology. Volume 15. Frontiers Media SA; 2024.","DOI":"10.3389\/fimmu.2024.1326753"},{"key":"15852_CR28","doi-asserted-by":"crossref","unstructured":"Topkan E, Kucuk A, Ozdemir Y et al. Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol. J Immunol Res. 2020;2020.","DOI":"10.1155\/2020\/8628540"},{"key":"15852_CR29","doi-asserted-by":"crossref","unstructured":"Senyurek S, Aygun MS, Kilic Durankus N et al. The Systemic Inflammation Response Index Efficiently Discriminates between the Failure Patterns of Patients with Isocitrate Dehydrogenase Wild-Type Glioblastoma Following Radiochemotherapy with FLAIR-Based Gross Tumor Volume Delineation. Brain Sci. 2024;14(9).","DOI":"10.3390\/brainsci14090922"},{"key":"15852_CR30","doi-asserted-by":"crossref","unstructured":"Friedmann-Morvinski D, Hambardzumyan D. Monocyte-neutrophil entanglement in glioblastoma. Journal of Clinical Investigation. Volume 133. American Society for Clinical Investigation; 2023.","DOI":"10.1172\/JCI163451"},{"key":"15852_CR31","doi-asserted-by":"crossref","unstructured":"Menter DG, Tucker SC, Kopetz S, et al. Platelets and cancer: A casual or causal relationship: Revisited. Cancer and Metastasis Reviews. Volume 33. Kluwer Academic; 2014. pp. 231\u201369.","DOI":"10.1007\/s10555-014-9498-0"},{"issue":"9","key":"15852_CR32","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1007\/s10072-022-06158-w","volume":"43","author":"X Shi","year":"2022","unstructured":"Shi X, Li H, Xu Y, et al. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients. Neurol Sci. 2022;43(9):5523\u201331.","journal-title":"Neurol Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15852-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15852-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15852-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:42:51Z","timestamp":1777509771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15852-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15852"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15852-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. Ethical approval was obtained from the SANKO University Faculty of Medicine Ethics Committee (Approval No: 2025\/11). The requirement for informed consent was waived due to the retrospective nature of the study by the SANKO University Faculty of Medicine Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"541"}}